HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Bradley S. Allen Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bolling, K. Articles by Feinberg, H. Search for Related Content PubMed PubMed Citation Articles by Bolling, K. Articles by Feinberg, H.

J Thorac Cardiovasc Surg 1997;113:994-1005
© 1997 Mosby, Inc.

SURGERY FOR CONGENITAL HEART DISEASE

MYOCARDIAL PROTECTION IN NORMAL AND HYPOXICALLY STRESSED NEONATAL HEARTS: THE SUPERIORITY OF BLOOD VERSUS CRYSTALLOID CARDIOPLEGIA

Received for publication July 16, 1996; revisions requested August 27, 1996; revisions received Feb. 13, 1997; accepted for publication Feb. 13, 1997. Address for reprints: Bradley S. Allen, MD, University of Illinois, Cardiothoracic Surgery Department, 840 S. Wood St., 417 CSB (M/C 958), Chicago, IL 60612.

Abstract

Objectives: Blood cardioplegia predominates in the adult because it provides superior myocardial protection, especially in the ischemically stressed heart. However, the superiority of blood over crystalloid cardioplegia in the pediatric population is unproved. Furthermore, because many pediatric hearts undergo a preoperative stress such as hypoxia, it is important to compare the different methods of protection in both normal and hypoxic hearts. Methods: Twenty neonatal piglets were supported by cardiopulmonary bypass and subjected to 70 minutes of cardioplegic arrest. Of 10 nonhypoxic hearts, five (group 1) were protected with blood cardioplegia and five (group 2) with crystalloid cardioplegia (St. Thomas' Hospital solution). Ten other piglets underwent 60 minutes of ventilator hypoxia (inspired oxygen concentration 8% to 10%) before cardioplegic arrest. Five (group 3) were then protected with blood cardioplegia and the other five (group 4) with crystalloid cardioplegia. Myocardial function was assessed by means of pressure volume loops and expressed as a percentage of control. Coronary vascular resistance was measured with each infusion of cardioplegic solution. Results: No difference waas noted between blood (group 1) or crystalloid cardioplegia (group 2) in nonhypoxic hearts regarding systolic function (end-systolic elastance 104% vs 103%), diastolic stiffness (156% vs 159%), preload recruitable stroke work (102% vs 101%), or myocardial tissue edema (78.9% vs 78.9%). Conversely, in hearts subjected to a hypoxic stress, blood cardioplegia (group 3) provided better protection than crystalloid cardioplegia (group 4) by preserving systolic function (end-systolic elastance 106% vs 40%; p < 0.05) and preload recruitable stroke work (103% vs 40%; p < 0.05); reducing diastolic stiffness (153% vs 240%; p < 0.05) and myocardial tissue edema (79.6% vs 80.1%); and preserving vascular function, as evidenced by unaltered coronary vascular resistance (p < 0.05). Conclusion: This study demonstrates that (1) blood or crystalloid cardioplegia is cardioprotective in hearts not compromised by preoperative hypoxia and (2) blood cardioplegia is superior to crystalloid cardioplegia in hearts subjected to the preoperative stress of acute hypoxia.

This article has been cited by other articles:

				A. F. Corno Systemic venous drainage: can we help Newton? Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1044 - 1051. [Abstract] [Full Text] [PDF]

				P. Modi, M.-S. Suleiman, B. C. Reeves, A. Pawade, A. J. Parry, G. D. Angelini, and M. Caputo Free Amino Acids in Hearts of Pediatric Patients With Congenital Heart Disease: The Effects of Cyanosis, Age, and Pathology. Ann. Thorac. Surg., March 1, 2006; 81(3): 943 - 949. [Abstract] [Full Text] [PDF]

				P. Modi, M.-S. Suleiman, B. C. Reeves, A. Pawade, A. J. Parry, G. D. Angelini, and M. Caputo Basal Metabolic State of Hearts of Patients With Congenital Heart Disease: The Effects of Cyanosis, Age, and Pathology Ann. Thorac. Surg., November 1, 2004; 78(5): 1710 - 1716. [Abstract] [Full Text] [PDF]

				T. A. Khan, C. Bianchi, P. Voisine, J. Feng, J. Baker, M. Hart, M. Takahashi, G. Stahl, and F. W. Sellke Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest J. Thorac. Cardiovasc. Surg., October 1, 2004; 128(4): 602 - 608. [Abstract] [Full Text] [PDF]

				B. S. Allen Pediatric myocardial protection: Where do we stand? J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 11 - 13. [Full Text] [PDF]

				P. Modi, M.-S. Suleiman, B. Reeves, A. Pawade, A.J. Parry, G.D. Angelini, and M. Caputo Myocardial metabolic changes during pediatric cardiac surgery: A randomized study of 3 cardioplegic techniques J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 67 - 75. [Abstract] [Full Text] [PDF]

				B. S. Allen Fetal cardiac surgery: Simplicity versus success in a new frontier J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1254 - 1256. [Full Text] [PDF]

				T. Doenst, C. Schlensak, and F. Beyersdorf Cardioplegia in pediatric cardiac surgery: do we believe in magic? Ann. Thorac. Surg., May 1, 2003; 75(5): 1668 - 1677. [Abstract] [Full Text] [PDF]

				M. Caputo, P. Modi, H. Imura, A. Pawade, A. J. Parry, M-S. Suleiman, and G. D. Angelini Cold blood versus cold crystalloid cardioplegia for repair of ventricular septal defects in pediatric heart surgery: a randomized controlled trial Ann. Thorac. Surg., August 1, 2002; 74(2): 530 - 535. [Abstract] [Full Text] [PDF]

				J. M. Pearl, D. P. Nelson, S. M. Schwartz, and P. B. Manning First-stage palliation for hypoplastic left heart syndrome in the twenty-first century Ann. Thorac. Surg., January 1, 2002; 73(1): 331 - 339. [Abstract] [Full Text] [PDF]

				M. T. Kronon, B. S. Allen, A. Halldorsson, S. Rahman, M. J. Barth, and M. Ilbawi Delivery of a nonpotassium modified maintenance solution to enhance myocardial protection in stressed neonatal hearts: A new approach J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 119 - 129. [Abstract] [Full Text] [PDF]

				H. Imura, M. Caputo, A. Parry, A. Pawade, G. D. Angelini, and M.-S. Suleiman Age-Dependent and Hypoxia-Related Differences in Myocardial Protection During Pediatric Open Heart Surgery Circulation, March 20, 2001; 103(11): 1551 - 1556. [Abstract] [Full Text] [PDF]

				B. S Allen and M. N Ilbawi Hypoxia, reoxygenation and the role of systemic leukodepletion in pediatric heart surgery Perfusion, January 1, 2001; 16(1_suppl): 19 - 29. [Abstract] [PDF]

				M. T. Kronon, B. S. Allen, K. S. Bolling, S. Rahman, T. Wang, H. S. Maniar, S. M. Prasad, and M. N. Ilbawi The role of cardioplegia induction temperature and amino acid enrichment in neonatal myocardial protection Ann. Thorac. Surg., September 1, 2000; 70(3): 756 - 764. [Abstract] [Full Text] [PDF]

				M. T. Kronon, B. S. Allen, S. Rahman, T. Wang, N. A. Tayyab, K. S. Bolling, and M. N. Ilbawi Reducing postischemic reperfusion damage in neonates using a terminal warm substrate-enriched blood cardioplegic reperfusate Ann. Thorac. Surg., September 1, 2000; 70(3): 765 - 770. [Abstract] [Full Text] [PDF]

				M. Nagashima, G. Nollert, U. Stock, J. Sperling, S. Hatsuoka, D. Shum-Tim, K. Takeuchi, A. Nedder, and J. E. Mayer Jr Cardiac performance after deep hypothermic circulatory arrest in chronically cyanotic neonatal lambs J. Thorac. Cardiovasc. Surg., August 1, 2000; 120(2): 238 - 246. [Abstract] [Full Text] [PDF]

				P. J. Chai, R. Nassar, A. E. Oakeley, D. M. Craig, G. Quick Jr, J. Jaggers, S. P. Sanders, R. M. Ungerleider, and P. A. W. Anderson Soluble Complement Receptor-1 Protects Heart, Lung, and Cardiac Myofilament Function From Cardiopulmonary Bypass Damage Circulation, February 8, 2000; 101(5): 541 - 546. [Abstract] [Full Text] [PDF]

				M. T. Kronon, B. S. Allen, A. Halldorsson, S. Rahman, T. Wang, and M. Ilbawi DOSE DEPENDENCY OF L-ARGININE IN NEONATAL MYOCARDIAL PROTECTION: THE NITRIC OXIDE PARADOX J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 655 - 664. [Abstract] [Full Text] [PDF]

				M. T. Kronon, B. S. Allen, A. Halldorsson, S. Rahman, T. Wang, and M. Ilbawi L-ARGININE, PROSTAGLANDIN, AND WHITE CELL FILTRATION EQUALLY IMPROVE MYOCARDIAL PROTECTION IN STRESSED NEONATAL HEARTS J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 665 - 673. [Abstract] [Full Text] [PDF]

				M. Kronon, K. S. Bolling, B. S. Allen, A. O. Halldorsson, T. Wang, and S. Rahman The importance of cardioplegic infusion pressure in neonatal myocardial protection Ann. Thorac. Surg., October 1, 1998; 66(4): 1358 - 1364. [Abstract] [Full Text] [PDF]

				A. O. Halldorsson, M. Kronon, B. S. Allen, S. Rahman, T. Wang, M. Layland, and D. Sidle Controlled reperfusion prevents pulmonary injury after 24 hours of lung preservation Ann. Thorac. Surg., September 1, 1998; 66(3): 877 - 885. [Abstract] [Full Text] [PDF]

				M. Kronon, K. S. Bolling, B. S. Allen, S. Rahman, T. Wang, A. Halldorsson, and H. Feinberg THE RELATIONSHIP BETWEEN CALCIUM AND MAGNESIUM IN PEDIATRIC MYOCARDIAL PROTECTION J. Thorac. Cardiovasc. Surg., December 1, 1997; 114(6): 1010 - 1019. [Abstract] [Full Text]